Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Operating cash flow minus capital expenditures
Percentile
P0
Near historical low
vs 2Y Ago
-2.9x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-55.54M | -66.5% |
| 2024 | $-33.36M | -276.2% |
| 2023 | $18.93M | +193.6% |
| 2022 | $-20.24M | +23.4% |
| 2021 | $-26.43M | - |